echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > The instrument market continues to take stock of important acquisitions in 2020

    The instrument market continues to take stock of important acquisitions in 2020

    • Last Update: 2022-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    【 】2020,,,。,,;,,,*;,,、。,,,,“”,2020,。
     

    Andrew Alliance
     
    Andrew Alliance
    20201,*,Andrew Alliance。
     

    Andrew Alliance、,,,、、,。
     

    IDES
     
    IDES
    20201,()INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC.
    (,IDES) ,,IDES。
     

    Established in 1949, Nippon Electronics, as a large-scale instrument manufacturer spanning more than half a century, occupies an important position in the fields of scientific/measurement instruments, industrial equipment, and medical equipment.
    According to previously released information, its flagship TEM system is designed to observe materials with atomic resolution and check their static structure.
    The unique technology of the acquired IDES company can upgrade these TEM systems to "ultra-fast time-resolved TEMs.
    " In addition, as an enterprise specializing in the research and development of transmission electron microscope related technologies, IDES also provides unique technologies related to high-speed electrostatic deflection and compression sensing.
    These technologies can be integrated into the TEM as an accessory to provide small Damaged, high-throughput TEM image acquisition.
    It can be said that this acquisition is technically even more powerful for Japan Electronics.

     

    NETZSCH acquires Malvern PANalytical's rheology business
     
    NETZSCH acquires Malvern PANalytical's rheology business
    On February 3, 2020, the industry's thermal analysis instrument manufacturer NETZSCH (NETZSCH) announced that it has successfully acquired two major rheology businesses under Malvern PANalytical, the Kinexus rotary rheometer and the Rosand capillary rheometer series.
    The acquisition of the two rheometer product series is an extension of the existing product line and an excellent complement to the established thermal analysis instruments.

     
    Analytical Instruments
    Malvern PANalytical's rheometer series has always had a good reputation in the industry.
    Rotational rheometers help maintain consistency and fluidity and other parameters, thereby predicting stability, texture and shelf life; capillary rheometers can optimize process conditions and material properties for key product functions.
    Combining rheometer data with thermal analysis data will help users perform material performance characterization more comprehensively, and more accurately formulate and optimize manufacturing processes.

     

      For NETZSCH, the acquisition will help it to further "conquer the city" in the polymer, pharmaceutical, cosmetics, asphalt and other business areas.

     

      Yongqing Environmental Protection acquires 51% equity of Hunan Changming and creditor's rights of related parties
     
    Yongqing Environmental Protection acquires 51% equity of Hunan Changming and creditor's rights of related parties
      On February 4, 2020, Yongqing Environmental Protection Co.
    , Ltd.
    (hereinafter referred to as Yongqing Environmental Protection) issued the "Announcement on the Company's Cash Acquisition of 51% Equity of Hunan Changming Environmental Protection Investment Co.
    , Ltd.
    and Related Party Credits and Related Transactions" The announcement stated that Yongqing Environmental Protection and Hunan Yongqing Environmental Technology Industry Group Co.
    , Ltd.
    (hereinafter referred to as Yongqing Group) and Hunan Changming Trading Co.
    , Ltd.
    (hereinafter referred to as Changming) signed the "Regarding Hunan Changming Environmental Protection Investment Co.
    , Ltd.
    Equity and Debt Transfer Agreement 》, acquired the 51% equity of Hunan Changming Environmental Protection Investment Co.
    , Ltd.
    (abbreviated as: Changming Environmental Protection) and creditor's rights of related parties for more than 12.
    34 million yuan in cash.

     

      Yongqing Environmental Protection takes this to further consolidate its strategy and industrial layout in the field of medical waste treatment, and achieve coordinated business development.

     

      Brooks acquires laboratory software company RURO Inc.

     
    Brooks acquires laboratory software company RURO Inc.

      In mid-February 2020, Brooks, a *provider of life sciences and semiconductor manufacturing automation solutions, announced that it had acquired laboratory information software company RURO, Inc.
    (hereinafter referred to as RURO) for US$15 million.

     

      RURO was founded in 2006 and is headquartered in the Biotechnology Corridor of Maryland, USA.
    It develops* computer software for research, biotechnology, pharmaceutical, healthcare, and government (homeland security) laboratories in the United States and Japan.
    According to previous Brooks news, the acquisition will merge the management of RURO with the sample management business of Brooks’ life sciences business unit.
    RURO’s product portfolio will enable Brooks to provide its customers with increasingly rich workflows, thereby enhancing its exposure to biological samples.
    On-site and off-site management of inventory and integrated solutions.

     

      Huatest Testing acquires Maritec, a marine oil testing company
     
    Huatest Testing acquires Maritec, a marine oil testing company
      On March 9, 2020, China Testing Testing and Certification Group Co.
    , Ltd.
    (hereinafter referred to as China Testing Testing) issued an announcement on the acquisition of equity of Maritec by a wholly-owned subsidiary.
    The announcement stated that it would purchase 100% of Maritec's equity for RMB 274 million.

     

      China Test Testing is a provider of third-party testing and certification services in my country.
    It is a comprehensive third-party organization integrating testing, calibration, inspection, certification and technical services, providing one-stop solutions for enterprises within the scope.
    Its extensive service network and strong technical capabilities have made it a listed company in the domestic testing industry.
    Maritec, which was acquired this time, was established in 1999.
    It is a marine fuel laboratory that provides analysis results and technical advice to shipping companies, and ranks among the top in the marine oil testing market.

     

      The scope of Maritec's business services can form a synergistic effect with the ship product line of China Test Testing.
    In recent years, the demand for marine oil in the Asia-Pacific market has grown rapidly, with marine oil accounting for more than 45% of the market share, and it has become a large marine oil consumer market.
    For China Test Testing, Maritec, headquartered in Singapore, is more conducive to seizing market opportunities in the Asia-Pacific region.

     

      Eppendorf acquires the Japanese centrifuge brand himac
     
    Eppendorf acquires the Japanese centrifuge brand himac
      On March 19, 2020, Eppendorf and Japan Koki Holdings Co.
    , Ltd.
    reached an agreement, Eppendorf will acquire Koki's centrifuge business as a whole, including its brand himac.

     

      Koki's predecessor was Hitachi Koki (Hitachi Koki), which was established in 1984.
    Since 1995, it manufactured * ultracentrifuge (model 40P), and has successively developed different types of high-speed refrigerated centrifuges, large-capacity refrigerated centrifuges, A full range of centrifuges such as micro-ultracentrifuge, production-type large-capacity continuous-flow ultra-speed centrifuge, floor-standing multi-function centrifuge, and desktop centrifuge.
    Himac centrifuge is a brand that can meet the needs from scientific research to production of new centrifuges.

     

      This acquisition marks an important step forward for Eppendorf to expand its centrifuge business, consolidating its strong market position and becoming one of the world's centrifuge manufacturers, which will contribute to the pharmaceutical and life science industries as well as academic and commercial research.
    The institution provides centrifuge products.

     

      Abcam acquires MGT
     
    Abcam acquires MGT
      On March 27, 2020, Abcam, a manufacturer of life science reagents and tools, announced the acquisition of the entire issued share capital of MarkerGene Technologies, Inc.
    (hereinafter referred to as MGT).

     

      MGT has a professional R&D team in the fields of biology, organic synthesis and fluorescence chemistry, and has rich experience in creating detection tools.
    Its proprietary detection development technology and labeling capabilities are the main targets of Abcam's acquisition.

     

      Danaher acquires GE Biopharma
     
    Danaher acquires GE Biopharma
      On April 1, 2020, Danaher Corporation (DHR) announced that it has completed the acquisition of the biopharmaceutical business from the life sciences division of General Electric Company (NYSE: GE).
    As part of Danaher, the business will be renamed Cytiva and will become an independent operating company in the Danaher Group's life science platform.

     

      Bó Lè acquires Celsee, a single-cell analysis company
     
    Bó Lè acquires Celsee, a single-cell analysis company
      On April 10, 2020, Bio-Rad announced that it has completed its plan to acquire Celsee, a single-cell analysis company.

     

      Celsee is a supplier of instruments and consumables for the separation, detection and analysis of single cells.
    The company's Genesis system provides scientists with a powerful, flexible, and extensible way to analyze and interpret cell behavior and collect key information about cells that were previously undetectable.
    The system can be used in proteomics, immune monitoring (replacement of flow cytometry), and next-generation sequencing library preparation.

     

      Hitachi High-tech acquires 100% equity of Tianmei Science Instrument
     
    Hitachi High-tech acquires 100% equity of Tianmei Science Instrument
      In mid-May 2020, Hitachi High-Technologies Corporation announced that it would acquire all the shares of Cosmos Technology Co.
    , Ltd.
    and its subsidiaries and merge the company into a wholly-owned subsidiary of Hitachi High-Technologies.

     

      Among them, TSL, a subsidiary of Tianmei Group, has been operating Hitachi's high-tech product sales and service businesses in China and Southeast Asia, including electron microscopes, spectrophotometers, and liquid chromatographs.
    The completion of this acquisition will help Hitachi High-tech to more directly support and serve the markets in China and Southeast Asia.

     

      Roche acquires Stratos Genomics, a nanopore sequencing technology company
     
    Roche acquires Stratos Genomics, a nanopore sequencing technology company
      At the end of May 2020, Roche announced that in order to further develop DNA sequencing technology for diagnostic services, it has acquired Stratos Genomics, a developer of nanopore sequencing.

     

      Stratos Genomics, headquartered in Seattle, Washington, is an early-stage sequencing technology company.
    It has developed a technology platform called Sequencing by Expansion (SBX), which is a fast nanopore DNA sequencing technology that can be used in Results can be produced in 60 minutes and only 15 minutes of hands-on time.
    SBX technology can be used for tumor targeted detection and whole genome detection to quickly diagnose diseases.

     

      The acquisition of Stratos Genomics is a complement to Roche's nanopore development technology, and its goal is to provide end-to-end sequencing solutions from patient samples to diagnostic results.

     

      Merck acquires Themis Bioscience
     
    Merck acquires Themis Bioscience
      Merck, the giant of vaccine development and production, announced at the end of May 2020 that it would acquire Themis through a subsidiary.

     

      Themis is a private company specializing in infectious diseases and cancer vaccines and immunomodulatory therapies.
    The Measles Vector Platform (Measles Vector Platform) created by it has developed a large number of candidate vaccines and immunomodulatory therapies.
    The platform is based on the vectors initially developed by the scientists of the Pasteur Institute and licensed to Themis for specific viral infection adaptations.
    The Pasteur Institute is currently the world’s European vaccine research institution.
    The acquisition is based on the cooperation between the two companies, using the measles virus vector platform to develop candidate vaccines, which is expected to accelerate Themis's development of new coronary pneumonia vaccine candidates.

     

      BD announces the completion of the acquisition of Straub Medical
     
    BD announces the completion of the acquisition of Straub Medical
      On June 9, 2020, BD officially announced the completion of the acquisition of Straub Medical.
    Headquartered in Vence, Switzerland, Straub Medical is a medical company that develops and sells mechanical atherectomy and thrombectomy for the treatment of peripheral arterial disease (PAD) and venous diseases.
    Through a network of direct sales subsidiaries and third-party distributors, its products are sold to more than 40 countries.

     

      Illumina acquires BlueBee due to Mena
     
    Illumina acquires BlueBee due to Mena
      On June 19, 2020, Illumina announced the acquisition of BlueBee.

     

      BlueBee has a secure and compliant cloud platform that simplifies access to data and tools, allowing users to easily obtain important information from genomic data.

     

      Integrating BlueBee's capabilities into IMNA cloud computing-related products will enable users to flexibly run custom analysis or access industry options such as the DRAGEN Bio-IT platform, thereby simplifying data processing and improving operational efficiency.
    This is an important supplement to Meina's cloud computing-related products.
    Among them, the BaseSpace Sequencing Hub cloud platform is one of the widely used sequencing operation management and data sharing software.

     

      Halma acquires Maxtec LLC
     
    Halma acquires Maxtec LLC
      Halma, a sex group dedicated to life safety technology, announced in early June 2020 the acquisition of Maxtec LLC in Utah, USA.

     

      Maxtec provides oxygen analysis and delivery products in medical and non-medical applications, including product design, manufacturing and distribution, especially oxygen sensors and analyzers in emergency wards of municipal hospitals.

     

      After the completion of the acquisition, Maxtec will be part of the Halma Medical Division and will be integrated into Perma Pure, another subsidiary of the division, for management.
    Perma Pure will provide medical dehumidification products that are also used in emergency rooms.

     

      Merck acquires Resolution Spectra Systems, a bioprocess analysis company
     
    Merck acquires Resolution Spectra Systems, a bioprocess analysis company
      In early July 2020, industry giant Merck announced the acquisition of Resolution Spectra Systems, a French bioprocess analysis company.

     

      Resolution Spectra System focuses on biological processing monitoring sensors based on Raman technology, which can provide real-time monitoring and process control of biological samples, and analyze many biological parameters, including glucose, lactic acid, active cell density and other related impurities, using a single probe All parameters can be monitored at the same time.

     

      After this acquisition, Merck will be able to provide unique and systematic life science solutions.

     

      LGC acquires The Native Antigen Company, a supplier of neocoronavirus antigens
     
    LGC acquires The Native Antigen Company, a supplier of neocoronavirus antigens
      In mid-August 2020, LGC, a life science tool company, announced the acquisition of The Native Antigen Company (NAC).

     

      NAC is the world's manufacturer of infectious disease antigens and related products.
    Products include pathogen receptors, virus-like particles and antibodies for immunoassay applications, vaccine development and quality control solutions.
    NAC is one of the first companies to provide antigens for the novel coronavirus and has played an important role in responding to the novel coronavirus.

     

      Bruker announces the acquisition of Canopy Biosciences, LLC
     
    Bruker announces the acquisition of Canopy Biosciences, LLC
      On September 11, 2020, Bruker announced the acquisition of Canopy Biosciences, LLC.
    Canopy Biosciences is a company in the field of high-path biomarker imaging such as immunology, immuno-oncology and cell therapy.
    Founded in 2016, the company has rapidly established a product and service portfolio covering gene editing, gene expression analysis and regulation, and bioprocessing in just a few years.
    Its gene editing product portfolio provides easy-to-use CRISPR kits and a full set of customized cell engineering services.
    In addition, an innovative multi-omics immunoassay platform has been assembled, including ultra-sensitive DNA sequencing (RareSeq), transcriptome sequencing (RNAseq), gene expression analysis, and detection of multiplexed proteins in cell and tissue samples through ChipCytometry.

     

      The acquisition enhances Bruker's ability to target multi-omics and products based on fluorescence imaging technology.

     

      Illumina acquires GRAIL for $8 billion in cash and stock
     
    Illumina acquires GRAIL for $8 billion in cash and stock
      On September 22, 2020, Illumina and GRAIL jointly announced that the two parties have reached a final agreement under which Illumina will acquire GRAIL for USD 8 billion in cash and stock.

     

      GRAIL is an independent company established by Illumina in 2016.
    Based on Illumina's next-generation gene sequencing technology (NGS), it develops cutting-edge data science and machine learning methods and creates a map of cancer signals in the blood.
    The multi-cancer early screening test Galleri developed by the company can detect more than 50 cancer types, of which more than 45 are screening methods that are not recommended by guidelines in the United States.

     

      Hexagon acquires DPTechnology, a developer and provider of computer-aided manufacturing (CAM) technology
     
    Hexagon acquires DPTechnology, a developer and provider of computer-aided manufacturing (CAM) technology
      On October 30, 2020, Hexagon Group, a provider of sensors, software and autonomous solutions, announced the signing of an agreement to acquire DPTechnology Corp.
    (hereinafter referred to as "DPTechnology"), a developer and provider of computer-aided manufacturing (CAM) technology.
    .

     

      DPTechnology was founded in 1982 and is headquartered in Camarillo, California, with approximately 260 employees in 27 locations.
    In addition, the dealer network covers 44 countries.
    Its flagship product ESPRIT system can provide high-performance CNC machine tool programming, optimization and simulation services for various precision manufacturing applications.
    After the completion of the acquisition, DPTechnology will be incorporated into the Hexagon Manufacturing Intelligence business unit for operations.

     

      Beckman Coulter acquires m2p-labs, manufacturer of micro-bioreactors
     
    Beckman Coulter acquires m2p-labs, manufacturer of micro-bioreactors
      Beckman Coulter Life Sciences (hereinafter referred to as Beckman Coulter) announced in mid-November 2020 to acquire m2p-labs, a manufacturer of micro-bioreactors in Germany.

     

      m2p-lab was established in 2005, funded by the Department of Biochemical Engineering and Electronic Engineering Materials Research Institute of RWTH Aachen University in Germany.
    It is a biotechnology company dedicated to the research and development of micro-reaction solution related equipment and support in biochemical engineering.
    The micro-reaction culture system it provides is widely used in high-throughput screening and biological research fields.
    After the completion of this acquisition, m2p-labs will begin the transition to Beckman Coulter's biotechnology business unit.

     

      Chuangyuan Technology intends to acquire 55% of Shanghai Beifen shares for RMB 82.
    39 million
     
    Chuangyuan Technology intends to acquire 55% of Shanghai Beifen shares for RMB 82.
    39 million
      On New Year’s Eve of 2021, Chuangyuan Technology issued an announcement that the company and Xu Ying, He Jihong, Shanghai Beifen Management Consulting Partnership (Limited Partnership) ("Beifen Partnership"), Shanghai Beifen Technology Co.
    , Ltd.
    ("Shanghai Beifen") (Or "subject company") has signed the "Share Transfer Agreement" on December 21, 2020, intending to acquire Xu Ying, He Jihong and Shanghai Beifen held by Beifen for 82.
    39 million yuan.

     

      Shanghai Beifen is specialized in technology development and system integration in the field of flue gas analysis and environmental protection gas online monitoring.
    Its main products are mainly divided into particulate matter online monitoring system, fixed pollution source gaseous pollutant online monitoring system (CEMS), VOCs online monitoring system, etc.
    Among them, the SBF800 series of products independently developed by Shanghai Beifen obtained the country's first ultra-low emission particulate matter online monitoring environmental protection certificate in 2015, and passed the recertification in 2018.

     

      After the completion of this transaction, Shanghai Beifen will become a holding subsidiary of Chuangyuan Technology and will be included in the company's consolidated statement.

     

      ZEISS invests in the acquisition of a majority stake in arivis AG
     
    ZEISS invests in the acquisition of a majority stake in arivis AG
      In late December 2020, Zeiss successfully acquired a majority stake in the imaging business of arivis AG.

     

      arivis AG is a fast-growing private software company dedicated to providing imaging science solutions for researchers and companies engaged in all aspects of life sciences (from basic research and discovery to applications).
    Its broad product portfolio and technical expertise enable arivis AG to meet the different requirements of industry and academia.

     

      This acquisition signifies that Zeiss will further strengthen its software capabilities and market position in 3D image visualization, image processing and research microscope analysis software.

     

      Original title: The instrument market cannibalize and constantly count important acquisitions in 2020
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.